Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
Aim: To investigate the prognostic value of lncRNA NR_046683 in multiple myeloma (MM).Methods: High-throughput lncRNA array was combined with bioinformatics techniques to screen differentially expressed lncRNA in MM. qRT-PCR was adopted to determine the expression of target lncRNAs in MM patients an...
Main Authors: | Hang Dong, Siyi Jiang, Yunfeng Fu, Yanwei Luo, Rong Gui, Jing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00045/full |
Similar Items
-
Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types
by: Yunzhen Wei, et al.
Published: (2020-08-01) -
The prognostic value and mechanisms of lncRNA UCA1 in human cancer
by: Yao F, et al.
Published: (2019-08-01) -
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
by: Qian Chen, et al.
Published: (2020-10-01) -
Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p
by: Xi Yang, et al.
Published: (2020-02-01) -
Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
by: Danfeng Li, et al.
Published: (2021-09-01)